Peroxiredoxin IV Protects Cells From Radiation-Induced Apoptosis in Head-and-Neck Squamous Cell Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 4, 2009, Pages 1196-1202

  Park, Jung Je ^a   Chang, Hyo Won ^b   Jeong, Eun Jeong ^b   Roh, Jong Lyel ^b   Choi, Seung Ho ^b   Jeon, Sea Yuong ^a   Ko, Gyung Hyuck ^a   Kim, Sang Yoon ^b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Apoptosis; Head and neck cancer; Peroxiredoxin IV; Radiation seisitivity; Reactive oxygen species

Indexed keywords

IONIZING RADIATION; OXYGEN;

ANTIOXIDANT ENZYMES; APOPTOSIS; CELL VIABILITIES; CLONOGENIC ASSAYS; HEAD-AND-NECK CANCER; HEAD-AND-NECK SQUAMOUS CELL CARCINOMATA; INDUCED APOPTOSIS; PEROXIREDOXIN IV; PEROXIREDOXINS; RADIATION-INDUCED APOPTOSIS; REACTIVE OXYGEN SPECIES; TUNEL ASSAYS;

CELL DEATH;

COMPLEMENTARY DNA; PEROXIREDOXIN; PEROXIREDOXIN IV; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL LINE; CELL PROTECTION; CELL VIABILITY; CLONE; CLONOGENIC ASSAY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; NICK END LABELING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; PEROXIREDOXINS; RADIATION TOLERANCE; REACTIVE OXYGEN SPECIES; TRANSFECTION;

EID: 61349110067     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.070     Document Type: Article

References (45)

1. Azzam E.I., de-Toledo S.M., and Little J.B. Stress signaling from irradiated to non-irradiated cells. Curr Cancer Drug Targets 1 (2004) 53-64
2. Guo G., Yan-Sanders Y., Lyn-Cook B.D., et al. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 23 (2003) 2362-2378
3. Rhee S.G., Kim K.H., Chae H.Z., et al. Antioxidant defense mechanisms: A new thiol-specific antioxidant enzyme. Ann N Y Acad Sci 738 (1994) 86-92
4. Weiss J.F., and Kumar K.S. Antioxidant mechanisms in radiation injury and radioprotection. In: Chow C.K. (Ed). Cellular antioxidant defense mechanisms (1998), CRC Press, Boca Raton, FL 163-189
5. Hirose K., Longo D.L., Oppenheim J.J., and Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 7 (1993) 361-368
6. Sun J., Chen Y., Li M., and Ge Z. Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Biol Med 24 (1998) 586-593
7. Suresh A., Tung F., Moreb J., and Zucali J.R. Role of manganese superoxide dismutase in radioprotection using gene transfer studies. Cancer Gene Ther 1 (1994) 85-90
8. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 15 (2003) 247-254
9. Jaruga E., Lapshina E.A., Biliński T., et al. Resistance to ionizing radiation and antioxidative defence in yeasts. Are antioxidant-deficient cells permanently stressed?. Biochem. Mol Biol Int 37 (1995) 467-473
10. 2-mediated cell death. Free Radic Biol Med 1 (2004) 53-64
11. Das K.C. Thioredoxin system in premature and newborn biology. Antioxid Redox Signal 6 (2004) 177-184
12. Fujii J., and Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional mammalian redox protein. Redox Rep 7 (2002) 123-130
13. Wood Z.A., Schröder E., Robin Harris J., and Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28 (2003) 32-40
14. Zhang B., Su Y., Ai G., et al. Involvement of peroxiredoxin I in protecting cells from radiation-induced death. J Radiat Res 46 (2005) 305-312
15. Wang T., Tamae D., LeBon T., et al. The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells. Cancer Res 65 (2005) 10338-10346
16. Echalier A., Trivelli X., Corbier C., et al. Crystal structure and solution NMR dynamics of a D (type II) peroxiredoxin glutaredoxin and thioredoxin dependent: A new insight into the peroxiredoxin oligomerism. Biochemistry 44 (2005) 1755-1767
17. Harris J.R., Schroder E., Isupov M.N., et al. Comparison of the decameric structure of peroxiredoxin-II by transmission electron microscopy and X-ray crystallography. Biochim Biophys Acta 1547 (2001) 221-234
18. Yang K.S., Kang S.W., Woo H.A., et al. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem 277 (2002) 38029-38036
19. Ishii T., Itoh K., Sato H., and Bannai S. Oxidative stress-inducible proteins in macrophages. Free Radic Res 31 (1999) 351-355
20. Neumann C.A., Krause D.S., Carman C.V., et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424 (2003) 561-565
21. Shau H., Huang A.C., Faris M., et al. Thioredoxin peroxidase (natural killer enhancing factor) regulation of activator protein-1 function in endothelial cells. Biochem Biophys Res Commun 249 (1998) 683-686
22. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic Biol Med 8 (1990) 583-599
23. Sato N., Iwata S., Nakamura K., et al. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J Immunol 154 (1995) 3194-3203
24. Jin D.Y., Chae H.Z., Rhee S.G., and Jeang K.T. Regulatory role for a novel human thioredoxinperoxidase in NF-κB activation. J Biol Chem 272 (1997) 30952-30961
25. Wong C.M., Chun A.C., Kok K.H., et al. Characterization of human and mouse peroxiredoxin IV:evidence for inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species. Antioxid Redox Signal 2 (2000) 507-518
26. Lee Y.S., Chang H.W., Jeong J.E., et al. Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity. Acta Otolaryngol 4 (2007) 1-7
27. Kim S.Y., Chu K.C., Lee H.R., et al. Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol 117 (1997) 775-784
28. Bernier J., and Cooper J.S. Chemoradiation after surgery for high-risk head and neck cancer patients: How strong is the evidence?. Oncologist 10 (2005) 215-224
29. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherpy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88 (2000) 876-883
30. Pignon J.P., Bourhis J., Domenege C., and Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative group. Meta-analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
31. Mikkelsen R.B., and Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22 (2003) 5734-5754
32. Takada Y., Hachiya M., Park S.H., et al. Role of reactive oxygen species in cells overexpressing manganese superoxide dismutase: Mechanism for induction of radioresistance. Mol Cancer Res 1 (2002) 137-146
33. Park S.H., Chung Y.M., Lee Y.S., et al. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin Cancer Res 6 (2000) 4915-4920
34. Chen W.C., McBride W.H., Iwamoto K.S., et al. Induction of radioprotective peroxiredoxin-I by ionizing irradiation. J Neurosci Res 70 (2002) 794-798
35. Chen M.F., Keng P.C., Shau H., et al. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression. Int J Radiat Oncol Biol Phys 64 (2006) 581-591
36. Chen M.F., Chen W.C., Wu C.T., et al. p53 status is a major determinant of effects of decreasing peroxiredoxin I expression on tumor growth and response of lung cancer cells to treatment. Int J Radiat Oncol Biol Phys 66 (2006) 1461-1472
37. Zhang Y., Emmanuel N., Kamboj G., et al. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22). Genes Chromosomes Cancer 40 (2004) 365-370
38. Kohlmann A., Schoch C., Schnittger S., et al. Molecular characterization of acute leukemias by use of microarray technology. Genes Chromosomes Cancer 37 (2003) 396-405
39. Lehtonen S.T., Svensk A.M., Soini Y., et al. Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 111 (2004) 514-521
40. Kowaltowski A.J., Netto L.E., and Vercesi A.E. The thiol-specific antioxidant enzyme prevents mitochondrial permeability transition. Evidence for the participation of reactive oxygen species in this mechanism. J Biol Chem 273 (1998) 12766-12769
41. Kowaltowski A.J., Vercesi A.E., Rhee S.G., and Netto L.E. Catalases and thioredoxin peroxidase protect Saccharomyces cerevisiae against Ca(2+)-induced mitochondrial membrane permeabilization and cell death. FEBS Lett 473 (2000) 177-182
42. Netto L.E., Kowaltowski A.J., Castilho R.F., and Vercesi A.E. Thiol enzymes protecting mitochondria against oxidative damage. Methods Enzymol 348 (2002) 260-270
43. Wonsey D.R., Zeller K.I., and Dang C.V. The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc Natl Acad Sci U S A 99 (2002) 6649-6654
44. Mu Z.M., Yin X.Y., and Prochownik E.V. Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. J Biol Chem 277 (2002) 43175-43184
45. Wood Z.A., Poole L.B., and Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300 (2003) 650-653